AISLABIE BLOODSTOCK LIMITED

AISLABIE BLOODSTOCK LIMITED

AISLABIE BLOODSTOCK LIMITED - Company Information

Print Friendly Version

AISLABIE BLOODSTOCK LIMITED

Company Registration Number:
06314676 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2017

Period of accounts

Start date: 01 January 2017

End date: 31 December 2017

AISLABIE BLOODSTOCK LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2017

Balance sheet
Notes

AISLABIE BLOODSTOCK LIMITED

Balance sheet

As at 31 December 2017


Notes
2017
2016


£
£
Fixed assets
Tangible assets: 2 1,693,416 1,224,237
Total fixed assets: 1,693,416 1,224,237
Current assets
Stocks: 2,835,000 2,281,000
Debtors:   239,185 89,104
Cash at bank and in hand: 67,311 172,792
Total current assets: 3,141,496 2,542,896
Creditors: amounts falling due within one year:   (10,699,155) (7,927,511)
Net current assets (liabilities): (7,557,659) (5,384,615)
Total assets less current liabilities: (5,864,243) (4,160,378)
Total net assets (liabilities): (5,864,243) (4,160,378)
Capital and reserves
Called up share capital: 100 100
Profit and loss account: (5,864,343) (4,160,478)
Shareholders funds: (5,864,243) (4,160,378)

The notes form part of these financial statements

AISLABIE BLOODSTOCK LIMITED

Balance sheet statements

For the year ending 31 December 2017 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 13 August 2018
and signed on behalf of the board by:

Name: F Nass
Status: Director

The notes form part of these financial statements

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2017

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2017

2. Tangible Assets

Total
Cost £
At 01 January 2017 1,594,554
Additions 529,672
At 31 December 2017 2,124,226
Depreciation
At 01 January 2017 370,317
Charge for year 60,493
At 31 December 2017 430,810
Net book value
At 31 December 2017 1,693,416
At 31 December 2016 1,224,237